Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Insulin Formulations: Types and Delivery01:27

Insulin Formulations: Types and Delivery

632
Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into...
632
Glucagon-like Receptor Agonists01:24

Glucagon-like Receptor Agonists

828
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
828

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Neuronal responses to cytokines limit intestinal hypermotility and systemic effects of colonic inflammation.

iScience·2026
Same author

Human enterotoxigenic <i>Escherichia coli</i> (ETEC) infections elicit antibodies that broadly neutralize mucinases of pathogenic <i>Escherichia coli</i> and <i>Shigella</i>.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

The B cell receptor-mTOR signaling axis restricts the accumulation of lung tissue-resident memory B cells after influenza infection.

Science immunology·2026
Same author

Soluble Antigen Arrays Alter the Response of Epitope-Specific Diabetogenic T Cells.

ACS applied bio materials·2026
Same author

Soluble Antigen Array Displaying Proinsulin(F25D) Selectively Targets Anti-insulin B Cells without Hormonal Effects.

Molecular pharmaceutics·2026
Same author

The Role of Proteases in Epithelial Dysregulation in Fungal Sinusitis.

International forum of allergy & rhinology·2026

相关实验视频

Updated: Jan 11, 2026

Intra-lymph Node Injection of Biodegradable Polymer Particles
09:06

Intra-lymph Node Injection of Biodegradable Polymer Particles

Published on: January 2, 2014

15.1K

工程设计的非激素,阴性亲胰岛素变体延长淋巴排水.

Grant M Downes1, Amber S Griffith2, Kyle D Apley3

  • 1Bioengineering Graduate Program, University of Kansas, Lawrence, Kansas 66045 United States.

Molecular pharmaceutics
|November 12, 2025
PubMed
概括

研究人员设计了具有阴性尾巴的亲胰岛素变体,以改善1型糖尿病的抗原特异性免疫疗法 (ASIT). 这种修改减缓了抗原的释放,增强了免疫耐受性,并可能减少了广泛免疫抑制的需要.

关键词:
抗原特异性免疫疗法 抗原特异性免疫疗法阴阳性亲胰岛素是什么?淋巴运输是指淋巴运输的过程.缓慢的抗原释放.皮下注射 皮下注射 皮下注射第1类糖尿病 1型糖尿病

更多相关视频

Validation of Therapeutic Agent Conjugation to Polyvinyl Alcohol-Coated Medical Devices
06:34

Validation of Therapeutic Agent Conjugation to Polyvinyl Alcohol-Coated Medical Devices

Published on: November 29, 2024

591
Intralymphatic Immunotherapy and Vaccination in Mice
07:33

Intralymphatic Immunotherapy and Vaccination in Mice

Published on: February 2, 2014

23.9K

相关实验视频

Last Updated: Jan 11, 2026

Intra-lymph Node Injection of Biodegradable Polymer Particles
09:06

Intra-lymph Node Injection of Biodegradable Polymer Particles

Published on: January 2, 2014

15.1K
Validation of Therapeutic Agent Conjugation to Polyvinyl Alcohol-Coated Medical Devices
06:34

Validation of Therapeutic Agent Conjugation to Polyvinyl Alcohol-Coated Medical Devices

Published on: November 29, 2024

591
Intralymphatic Immunotherapy and Vaccination in Mice
07:33

Intralymphatic Immunotherapy and Vaccination in Mice

Published on: February 2, 2014

23.9K

科学领域:

  • 免疫学 免疫学 免疫学
  • 内分泌学 在内分泌学.
  • 生物技术是生物技术.

背景情况:

  • 1型糖尿病包括针对胰腺小岛自身抗原的自身抗体,特别是亲胰岛素.
  • 目前的抗原特异性免疫疗法 (ASIT) 面临着由于抗原稳定性差和快速清除的挑战.
  • 现有的ASIT通常需要全球免疫抑制,带来显著的副作用.

研究的目的:

  • 为增强抗原特异性免疫疗法 (ASIT) 设计稳定,非荷尔蒙性亲胰岛素变体.
  • 为了研究这些修改后的亲胰岛素变体的药理动力学和药理动力学特性.
  • 评估这些变异的潜力,以提高ASIT在1型糖尿病的疗效.

主要方法:

  • 工程设计的非荷尔蒙性亲胰岛素变体,具有C-终端阴离子尾.
  • 评估对抗胰岛素抗体和胰岛素受体的结合亲和力.
  • 在氨酸凝模型中评估了物理稳定性和扩散特性.
  • 模拟皮下注射以观察抗原释放动力学.

主要成果:

  • 阴阳性亲胰岛素变体保持了对抗胰岛素抗体的低nM结合亲和力和低胰岛素受体亲和力.
  • 这些变种的物理稳定性与原生亲胰岛素相当.
  • 阴离子修饰显著减缓了亲胰岛素扩散,产生了储存效应并延长了抗原的存在.
  • 缓慢释放导致持续的亲胰岛素积累在排水淋巴结.

结论:

  • 亲胰岛素的阴离子修饰为开发储存式抗原递送系统提供了一个有希望的策略.
  • 这种方法可以通过延长抗原暴露和向淋巴结来提高ASIT的疗效.
  • 工程变体具有改善1型糖尿病治疗的潜力,通过在没有全球免疫抑制的情况下促进免疫耐受性.